HOME >> MEDICINE >> NEWS
UK researchers find new class of nontoxic cancer treatments

LEXINGTON, Ky. (May 1, 2007) -- A new class of compounds developed by two University of Kentucky researchers shows promise as a nontoxic treatment of some cancers previously treated with toxic chemotherapy, the researchers report today.

In a study published in the April 30 issue of the academic journal Chemistry & Biology, UK pharmaceutical sciences graduate student Abby Ho mentored by assistant professor Kyung-Bo Kim and ophthalmology and visual sciences assistant professor Royce Mohan describe a compound that acts directly on LMP2, a component of the immune proteasome variant that has been identified abundantly expressed in certain types of tumors, including some prostate cancers.

The compound, dubbed UK-101, inhibits LMP2 while not attacking normal cells, indicating that it could be an effective cancer treatment that does not produce the kinds of unpleasant side effects reported by many patients currently treated with broadly acting proteasome inhibitors and chemotherapeutics. Kim and Mohan also suggest that UK-101 may be useful in treating a number of diseases in which LMP2 is involved. The researchers are particularly excited about UK-101s potential in treating inflammatory conditions associated with arthritis, rheumatism and cardiovascular diseases.

The researchers report success in using the compound in tests in prostate cancer cells. Importantly, Kim and Mohan point out that in test using highly sensitive vascular endothelial cells obtained from blood vessels that UK-101 was found to be non toxic because they lacked expression of this LMP2 immunoproteasome target.


'"/>

Contact: Dan Adkins
dan.adkins@insightbb.com
859-257-1754
University of Kentucky
1-May-2007


Page: 1

Related medicine news :

1. Stanford researchers find culprit in aging muscles that heal poorly
2. UCLA researchers awarded $9M contract for study identifiying antibiotic treatment for MRSA
3. Penn researchers discover novel pathway for increasing good cholesterol
4. Theory of facial aging gets a facelift from UT Southwestern researchers
5. UIC researchers to develop new drugs to fight bioterrorism
6. UQ researchers discover some of the oldest forms of life
7. U of M researchers discover new method to combat HIV
8. U of M researchers assess effectiveness of computerized physician order entry system
9. Nepalese researchers identify cost-effective treatment for drug-resistant typhoid
10. Physician-researchers often less successful in obtaining NIH funding
11. UCLA researchers develop new nanomaterials to deliver anti-cancer drugs to cells

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/23/2019)... ... July 23, 2019 , ... Denver-based Blue Dog Designs, makers of the ... (CRI), is pleased to announce the winner of the 2019 Help ‘Em Out ... technician at Blue Pearl Veterinary Partners of New York. Previously, Arbitman ...
(Date:7/23/2019)... ... July 23, 2019 , ... Nightingale College, a fully accredited ... programs to Dodge City and Manhattan, Kansas. Local hospitals and health care facilities ... accessible by allowing learners the flexibility of completing all didactic courses online and ...
(Date:7/23/2019)... MILFORD, Pa. (PRWEB) , ... July 23, 2019 , ... ... has recently launched a new online custom pipe marker designer , allowing customers ... tool provides design flexibility and convenience and takes just minutes to use. , ...
(Date:7/23/2019)... ... 23, 2019 , ... Ziegler, a national specialty investment bank, ... companies that provide products, services and technology to the aging marketplace, announced today ... to 5:00 p.m. at Ziegler’s corporate headquarters, located at One North Wacker in ...
(Date:7/23/2019)... ... July 23, 2019 , ... NeoTract, a wholly owned ... of urology, today announced that Bradley Wilson, MD, Norman Urology Associates in Norman, ... that Dr. Wilson has achieved a high level of training and experience with ...
Breaking Medicine News(10 mins):
(Date:7/19/2019)... , ... July 19, 2019 , ... ... vasodilator) device. D’OXYVA is a novel non-invasive transdermal (over-the-skin) technology, which is the ... depth and breadth of the clinical evidence obtained by Circularity over the past ...
(Date:7/19/2019)... , ... July 19, 2019 , ... ... a GLC company, has named Jorge Bacigalupo Director of Education Strategy. , ... currently includes education delivered on six continents and in ten languages. AGILE has ...
(Date:7/18/2019)... ... 18, 2019 , ... Joining PAINWeek, the largest US pain ... courses on Saturday, September 7. PAINWeek faculty members James Fricton, DDS, MS, President ... Member and Pain Specialist, will lead these skills training courses, Transformative Care for ...
Breaking Medicine Technology:
Cached News: